FDA approves biosimilar to treat wet AMD ➤ First patient dosed in Phase 1/2 study for infectious conjunctivitis ➤ First patient dosed in Phase 3 trial for investigational retinitis pigmentosa ...

If refractive surgeons—and the industry that supports them—had a motto, it probably would be to never settle. Just look at the evolution of LASIK treatment planning ecosystems and treatment ...

Corneal crosslinking (CXL) has fundamentally changed the management of progressive keratoconus by providing a treatment intended to alter the natural history of disease rather than simply rehabilitate ...

The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus across pediatric, adolescent, and adult populations in a diverse U.S.

In the past, this section of EyeWorld has delved into nuanced glaucoma subtypes. In this issue, Won Kim, MD, and Maria Charria, MD, get into the specifics related to traumatic glaucoma. There are many ...

Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company ne ...

“You can’t really know where you are going until you know where you have been.” This adage applies to a paper recently published in the Journal of Cataract & Refractive Surgery (JCRS), adding to the ...

While ophthalmologists agree that glaucoma drops are not likely to go extinct as part of glaucoma management, recent innovation continues to shift their place in many physicians’ glaucoma treatment ...

What’s the latest tool in the refractive surgeon’s toolbox? As with many fields from marketing to medicine, it’s artificial intelligence (AI). EyeWorld spoke with several surgeons to learn more about ...

During the COVID-19 pandemic, ophthalmic practices turned to telemedicine to be able to stay in contact with their patients and get them the care they needed. In this article, two physicians discussed ...

Currently, corneal cell therapy is being investigated as a new approach for patients in need of corneal transplantation and treatment for corneal diseases. EyeWorld spoke to several physicians who ...

Rosacea can be a significant problem for many patients and may be more prevalent than physicians think. Depending on the subtype, there may be ocular involvement. Albert Cheung, MD, Vincent de Luise, ...